Today: 12 April 2026
Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up
30 December 2025
2 mins read

Lululemon stock slips today as founder Chip Wilson launches proxy fight over board shake-up

NEW YORK, December 30, 2025, 14:50 ET — Regular session

  • lululemon shares fell about 0.6% as founder Chip Wilson pushed a proxy contest for board changes.
  • The company said its board will review Wilson’s nominees and outline a recommendation ahead of the 2026 annual meeting.
  • The challenge lands amid a CEO transition after Calvin McDonald said he will step down on Jan. 31.

Shares of lululemon athletica inc. fell about 0.6% to $211.30 in afternoon trading on Tuesday after founder Chip Wilson launched a proxy fight — a campaign to win shareholder votes for board seats — seeking to reshape the board. The stock had gained about 2% on Monday, Reuters reported.

The board fight comes as the athletic apparel maker searches for a permanent chief executive after Calvin McDonald said he would step down on Jan. 31. Chief financial officer Meghan Frank and chief commercial officer André Maestrini are set to serve as interim co-CEOs, the company said.

Why it matters now: lululemon shares have lost nearly half their value in 2025 as the company has struggled to regain momentum with younger, affluent shoppers and faced fast-growing rivals such as Alo Yoga and Vuori. Activist pressure has also risen after Elliott Management disclosed a stake earlier this month, Reuters reported.

Wilson said he has nominated former On Running co-CEO Marc Maurer, former ESPN chief marketing officer Laura Gentile and former Activision CEO Eric Hirshberg for election at the 2026 annual meeting. He also plans to press for the board to be “declassified” — meaning all directors would face annual elections rather than staggered terms — a filing showed. Reuters+1

lululemon said its board will evaluate the nominees under its governance process and urged shareholders not to take any action for now. The company said it had asked Wilson to share nominee names earlier in an effort to avoid a “costly and distracting” contest, but he declined until submitting his notice. SEC

“Adding three new board members seems like something that Lululemon would be willing to do,” Morningstar analyst David Swartz said, while noting only Maurer has direct experience in the category. Reuters

The move in lululemon contrasted with a largely steady broader market, with the SPDR S&P 500 ETF down slightly and the consumer discretionary sector off about 0.2%. Athletic-apparel peers were mixed, with Nike down marginally while Under Armour jumped more than 8%.

Wilson holds a 4.27% stake in lululemon as of December, according to LSEG data cited by Reuters. A person familiar with his thinking told Reuters he was not working with any other investor on the board challenge.

Elliott disclosed a roughly $1 billion stake earlier this month, and Reuters has reported the activist had been working with former Ralph Lauren executive Jane Nielsen as a possible CEO candidate. Wilson has spoken with Nielsen but would not support a CEO selected before board changes, the source said.

In its response, lululemon defended its board’s record and pointed to shareholder returns, saying cumulative share repurchases since fiscal 2015 exceed $5.5 billion. The company also said it expects fiscal 2025 revenue of about $11.0 billion based on its guidance.

Investors are now watching for the next round of filings ahead of the 2026 annual meeting, including the company’s definitive proxy statement and any detailed platform from Wilson’s camp. The CEO search remains a near-term swing factor, with the board describing its aim to find a leader who can guide the company through “growth and transformation.” SEC+1

lululemon trades at about 11 times earnings, according to market data, keeping sentiment tightly tied to governance headlines and any clarity on leadership in the weeks ahead.

Stock Market Today

  • Moderna (MRNA) Stock Rises on FDA Flu Vaccine Review Optimism and Institutional Buying
    April 12, 2026, 3:05 PM EDT. Moderna's (MRNA) shares gained momentum as the FDA reviews its flu vaccine, with a decision expected by August. Institutional investors like Fidelity and BNP Paribas increased holdings, and Goldman Sachs raised its price target. The stock, once a one-hit wonder after peaking near $500 and dropping below $12, bounced to around $53, showing strong technical support around $46-$50. Despite 10% revenue growth guidance, Moderna leads the S&P 500 in short interest due to mRNA flu shot efficacy doubts and patent disputes. Insider sales continue, with no recent purchases. Hedge funds show mixed activity: 261 increased stakes while 318 decreased them, highlighting divided sentiment amid regulatory optimism and ongoing challenges.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib
Previous Story

Why Cogent Biosciences stock is down today after its FDA filing for bezuclastinib

Why Caris Life Sciences (CAI) stock is down today as biotech slips
Next Story

Why Caris Life Sciences (CAI) stock is down today as biotech slips

Go toTop